Bipenquinate

CAS No. 96201-88-6

Bipenquinate( —— )

Catalog No. M22085 CAS No. 96201-88-6

Bipenquinate is a potent and selective inhibitor of dihydroorotate dehydrogenase (DHODH) with IC50 of 20 nM, blocking de novo pyrimidine biosynthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 67 In Stock
2MG 31 In Stock
5MG 57 In Stock
10MG 93 In Stock
25MG 172 In Stock
50MG 219 In Stock
100MG 308 In Stock
200MG 434 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bipenquinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Bipenquinate is a potent and selective inhibitor of dihydroorotate dehydrogenase (DHODH) with IC50 of 20 nM, blocking de novo pyrimidine biosynthesis.
  • Description
    Bipenquinate is a potent and selective inhibitor of dihydroorotate dehydrogenase (DHODH) with IC50 of 20 nM, blocking de novo pyrimidine biosynthesis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    DHODH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    96201-88-6
  • Formula Weight
    397.36
  • Molecular Formula
    C23H14F2NNaO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [Na+].Cc1c(nc2ccc(F)cc2c1C([O-])=O)-c1ccc(cc1)-c1ccccc1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Li S F , Gong M J , Sun Y F , et al. Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo[J]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, 116:108982.
molnova catalog
related products
  • Enasidenib mesylate

    Enasidenib mesylate (AG-221 mesylate) is a potent and selective IDH2 mutase inhibitor that promotes differentiation of leukemia myeloid cells for the treatment of acute myeloid leukemia.

  • AGI-6780

    AGI-6780 is a potent and selective inhibitor of IDH2 R140Q mutant with IC50 of 23 nM.

  • Enoxolone

    Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption.